CRBP $40 TARGET HIT, IS THE 1.618 $60 EXTENSION NEXT?In this update, we delve into the latest developments with Corbus Pharmaceuticals (CRBP), examining whether the recent hit of our $40 target will lead to a correction to $32-$33 or propel the stock directly towards the $50s. With the 1.618 extension potentially setting a target at $59, we analyze the possibilities and implications for traders and investors.
CRBP trade ideas
CRBP $40 Target post breakout on trackCRBP Correction to the .618 level followed by a sideways triangle breakout that was very easy to see is heading towards my $40 target, based on the retracement our extension should actually get into the GETTEX:50S or $60s but my first conservative swing trade target is $40 psych.
CRBP on it's way to my $40 target, $32 is next though...In today's analysis on TradingView, we're diving into the latest developments in the market. Join us as we examine key trends, potential breakout points, and short-term targets. Stay informed and make data-driven decisions for your trades. (Date: 2/21/2024)
Short term is bearish to sideways then bullishWeek Ahead Glance on Corbus Pharmaceuticals (Ticker: CRBP) as of February 4th, 2024, by Candlestick Ninja! 🌟 Discover the latest insights into CRBP's recent explosive breakout to $40, forming a bullish head and shoulders pattern. We'll explore how it temporarily weakened under $27.50 and why a break of $27.50, eventually $29, could propel us to $35 swiftly.
I
Soars and Settles, what's next?🚀 Corbus Pharmaceuticals (Ticker: CRBP) made headlines on January 26th, 2024, as its shares skyrocketed an astonishing 207% following the groundbreaking Phase 1 Cancer Study results for patients with nectin-4 positive tumors. 🌟
In this video, we delve into the incredible journey of CRBP stock, breaking down the technical analysis that fueled its meteoric rise. The stock hit a psychological resistance level just below $40 before retracing to the .618 Fibonacci level around $18 and finding support. Currently settling around the $24-$25 .382 Fibonacci retracement level, CRBP appears poised for further gains.
📈 We explore the key levels to watch, with a critical focus on the $29 breakout point, which could propel the stock to $35 and potentially even $40. A breach of the $40 resistance level might pave the way for an exciting journey into the $60 to $80 range.
Whether you're a seasoned trader or a curious investor, this video provides valuable insights into CRBP's recent surge and potential future movements. Don't miss out on understanding the technical factors influencing the stock's trajectory and the possible scenarios that could unfold in the coming weeks.
CRBP Weekly AnalysisHello Traders!
The probability of what I analyzing, is to be true unless the opposite is proven
According to my analysis, this is my opinion about weekly chart for CORBUS PHARMACEUTICALS HOLDINGS (CRBP)
Feel free dear trader to share with me your opinion, and also your analysis & Keep Watching
#CRBP Possible Targets : $2.60 - 3.90 - 7.86 - 9.90Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA.
Targets : $2.60 - 3.90 - 7.86 - 9.90
**Disclaimer - not financial advice, please trade with caution and on your own risk. This prediction Based on My Dreams.
I would appreciate your feedback on my analysis. Do not view this idea as a recommendation for trading or investing.
CRBP potential golden cross Fundamentals have been rough as of lately for CRBP. phase 3 reaching a critical pivot point for their most recent potential product. this aside, technically speaking we are gathering a cluster of moving averages with the captain 200 day MA getting ready to cross the 9,20,50. Im semi bullish because of its current consolidation its forming on the daily chart, going to need to see price break out of white downward trend line then through the somewhat potential megaphone pattern seen with bottom support line.
Not financial advice: do your dd!
CRBP phase 3 and phase 2 data comingNo investment advice!
I do this only for practicing.
Most info on the Chart
June 2-5 there are coming Data of their Lenabasum
We might see a continoung pre run up before the data will be released.
Cannabis related stock, as the cannabis sector is heating up.
Depending on the Data wie might see a big upside breakout, or back sub 1.
CRBP double or triple jump very very soon! Been watching this stock for a bit. It finally is about to cross 200MA a strong indicator that it will pop soon and it's jumping (crossed above $2.5 about two days ago and touching $2 now. Put your bets in....timing is everything and it's starting to get hot!
Chaos Theory and Fractals: A forgotten name in HealthcareAbout the Tickers: Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP is a clinical-stage company focused on the development and commercialization of novel medicines designed to target the endocannabinoid system. The Company’s lead product candidate, lenabasum, is a novel, oral, selective cannabinoid receptor type 2 (CB2) agonist designed to provide an alternative to immunosuppressive medications in the treatment of chronic inflammatory and fibrotic diseases. Lenabasum is currently being evaluated in dermatomyositis and systemic lupus erythematosus. Corbus is also developing a pipeline of other preclinical drug candidates from its endocannabinoid system platform. Phase 3 trial of Lenabasum in Systemic Sclerosis was unsuccessful last year. Currently, a phase 3 trial in Dermatomyositis is scheduled to read out top line results by Q2 2021.
The Chart: Appears similar to Cassava NASDAQ:SAVA which also saw setbacks and plunged to about $1 a share. Can we use fractals and chaos theory to predict the price of $CRBP stock in the near term? Possibly.
Corbus Pharmaceuticals ($CRBP) is currently trading at about $2 a share. Cassava Sciences ($SAVA) is trading at about $54 a share.